Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial
Abstract Background To determine the efficacy and safety of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in Chinese adults with type 2 diabetes mellitus (T2DM). Methods In this single-center, double-blinded, randomized, placebo-controlled phase II trial, 91 patients were randomly assigned...
Main Authors: | Li Zang, Yijun Li, Haojie Hao, Jiejie Liu, Yu Cheng, Bing Li, Yaqi Yin, Qian Zhang, Fei Gao, Haibin Wang, Shi Gu, Jia Li, Fengxiang Lin, Yingfei Zhu, Guanglei Tian, Yulong Chen, Weijun Gu, Jin Du, Kang Chen, Qinghua Guo, Guoqing Yang, Yu Pei, Wenhua Yan, Xianling Wang, Junhua Meng, Saichun Zhang, Jianming Ba, Zhaohui Lyu, Jingtao Dou, Weidong Han, Yiming Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-022-02848-6 |
Similar Items
-
Isolation, Characterization, and In Vitro Differentiation of Mesenchymal Stem Cells from Human Umbilical Cord into Islet-Like Clusters
by: Mohammad Mahboob Kanafi, et al.
Published: (2017-09-01) -
Metformin and Gegen Qinlian Decoction boost islet α-cell proliferation of the STZ induced diabetic rats
by: Li Xu, et al.
Published: (2022-07-01) -
What is a β cell? – Chapter I in the Human Islet Research Network (HIRN) review series
by: Klaus H. Kaestner, et al.
Published: (2021-11-01) -
The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering
by: Ekaterine Berishvili, et al.
Published: (2024-03-01) -
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation
by: Beatrice Xuan Ho, et al.
Published: (2024-04-01)